Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,855 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TIPS Reduction by Parallel Placement of Amplatzer Vascular Plug and Stent.
Tsuchiya S, Koizumi J, Kondo T, Fujiwara K, Kato N, Fujimoto H, Uno T. Tsuchiya S, et al. Among authors: kato n. Cardiovasc Intervent Radiol. 2023 Aug;46(8):1107-1110. doi: 10.1007/s00270-023-03506-x. Epub 2023 Jul 6. Cardiovasc Intervent Radiol. 2023. PMID: 37414840 No abstract available.
Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma.
Yoshida R, Koroki K, Makishima H, Ogasawara S, Ishino T, Ogawa K, Nakagawa M, Fujiwara K, Unozawa H, Iwanaga T, Fujita N, Sakuma T, Kanzaki H, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Suzuki E, Ooka Y, Nakamoto S, Tawada A, Chiba T, Arai M, Kaneko T, Wakatsuki M, Kato J, Tsuji H, Kato N. Yoshida R, et al. Among authors: kato j, kato n. Case Rep Oncol. 2021 Jul 15;14(2):1103-1110. doi: 10.1159/000517440. eCollection 2021 May-Aug. Case Rep Oncol. 2021. PMID: 38075390 Free PMC article.
Use of disposable endoscope for variceal sclerotherapy.
Fujiwara K, Kondo T, Fujimoto K, Fujie M, Kanogawa N, Ogasawara S, Kato N. Fujiwara K, et al. Among authors: kato n. Endoscopy. 2023 Dec;55(S 01):E1248-E1249. doi: 10.1055/a-2215-1100. Epub 2023 Dec 15. Endoscopy. 2023. PMID: 38101451 Free PMC article. No abstract available.
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.
Fujiwara K, Kondo T, Fujimoto K, Yumita S, Ogawa K, Ishino T, Nakagawa M, Iwanaga T, Tsuchiya S, Koroki K, Kanzaki H, Inoue M, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Ogasawara S, Nakamoto S, Chiba T, Koizumi J, Kato J, Kato N. Fujiwara K, et al. Among authors: kato j, kato n. J Gastroenterol. 2024 Jun;59(6):515-525. doi: 10.1007/s00535-024-02097-9. Epub 2024 Apr 7. J Gastroenterol. 2024. PMID: 38583112
Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells.
Iwanaga T, Chiba T, Nakamura M, Kaneko T, Ao J, Qiang N, Ma Y, Zhang J, Kogure T, Yumita S, Ishino T, Ogawa K, Kan M, Nakagawa M, Fujiwara K, Fujita N, Sakuma T, Kanzaki H, Koroki K, Kusakabe Y, Inoue M, Kobayashi K, Kanogawa N, Kiyono S, Kondo T, Nakagawa R, Ogasawara S, Nakamoto S, Muroyama R, Kato J, Kanda T, Maruyama H, Mimura N, Honda T, Murayama T, Nakamura H, Kato N. Iwanaga T, et al. Among authors: kato j, kato n. Biochem Biophys Res Commun. 2023 Jan 29;642:192-200. doi: 10.1016/j.bbrc.2022.12.025. Epub 2022 Dec 10. Biochem Biophys Res Commun. 2023. PMID: 36586187
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.
Ogawa K, Chiba T, Nakamura M, Arai J, Zhang J, Ma Y, Qiang NA, Ao J, Yumita S, Ishino T, Kan M, Iwanaga T, Nakagawa M, Fujiwara K, Sakuma T, Kanzaki H, Koroki K, Kusakabe Y, Kobayashi K, Kanogawa N, Kiyono S, Kondo T, Nakagawa R, Ogasawara S, Muroyama R, Nakamoto S, Kanda T, Maruyama H, Kato J, Matsumoto S, Arai T, Motohashi S, Kato N. Ogawa K, et al. Among authors: kato j, kato n. Anticancer Res. 2023 Mar;43(3):1043-1052. doi: 10.21873/anticanres.16249. Anticancer Res. 2023. PMID: 36854524
3,855 results